Showing results (151-160 of 224) with videos related to

Sort By:
Pageof 23
Annals of Surgical Oncology|February 2, 2008
Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic studyEelco de Bree, Hilde Rosing, Dimitris Filis, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2020
Concomitant intake of abiraterone acetate and food to increase pharmacokinetic exposure: real life data from a therapeutic drug monitoring programmeStefanie L Groenland, Merel van Nuland, Andries M Bergman, et al.
Journal of the American Society for Mass Spectrometry|September 12, 2009
Electrospray ionization quadrupole ion-mobility time-of-flight mass spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the therapeutic monoclonal antibody trastuzumabCarola W N Damen, Weibin Chen, Asish B Chakraborty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2009
Phase I pharmacokinetic and pharmacodynamic study of Carboplatin and topotecan administered intravenously every 28 days to patients with malignant solid tumorsDavid S Boss, Wandena S Siegel-Lakhai, Nadja E van Egmond-Schoemaker, et al.
Rapid Communications in Mass Spectrometry : RCM|June 25, 2004
Quantitative analysis of D-24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometryEllen Stokvis, Lianda G A H Nan-Offeringa, Mariët Ouwehand, et al.
European Journal of Clinical Pharmacology|February 13, 2018
The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastasesBart A W Jacobs, Nikol Snoeren, Morsal Samim, et al.
British Journal of Clinical Pharmacology|August 2, 2018
Therapeutic drug monitoring of small molecule kinase inhibitors in oncology in a real-world cohort study: does age matter?Marie-Rose B S Crombag, Jacobine G C van Doremalen, Julie M Janssen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2020
Therapeutic drug monitoring of imatinib in patients with gastrointestinal stromal tumours - Results from daily clinical practiceNikki S IJzerman, Stefanie L Groenland, Anne Miek Koenen, et al.
Cancer Chemotherapy and Pharmacology|July 12, 2002
Urinary and fecal excretion of topotecan in patients with malignant solid tumoursVirginie M M Herben, nadja E Schoemaker, Hilde Rosing, et al.
Neoplasia (New York, N.Y.)|February 4, 2010
Phase 1 study of combination treatment with PTK 787/ZK 222584 and cetuximab for patients with advanced solid tumors: safety, pharmacokinetics, pharmacodynamics analysisMarlies H G Langenberg, Petronella O Witteveen, Nienke A G Lankheet, et al.
Pageof 23